Lower Urinary Tract Symptoms Screening Questionnaire (LUTS-2)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier:
NCT01616810
First received: August 26, 2011
Last updated: June 8, 2012
Last verified: June 2012
  Purpose

The purpose of this study is to determine the validity of a screening tool which has been designed to detect the presence or absence of lower urinary tract symptoms in the general female population.


Condition
Cystocele

Study Type: Observational
Official Title: Lower Urinary Tract Symptoms Screening Questionnaire Validation STudy

Resource links provided by NLM:


Further study details as provided by St. Michael's Hospital, Toronto:

Primary Outcome Measures:
  • Presence or absence of lower urinary tract symptoms in the general female population [ Time Frame: Five years ] [ Designated as safety issue: No ]
    To validate the effectiveness of a screening tool in detecting the presence or absence of lower urinary tract symptoms in the general female population.


Enrollment: 300
Study Start Date: January 2007
Study Completion Date: December 2011
Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
observation
Healthy participants

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy participants, 18 years of age and older with any gynecological symptoms other than lower urinary tract symptoms or pelvic floor dysfunction

Criteria

Inclusion Criteria:

  • Healthy participants, 18 years of age and older with any gynecological symptoms

Exclusion Criteria:

  • Patients with lower urinary tract symptoms and pelvic floor dysfunction
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01616810

Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Dana Soroka, MD, FRCS(C) St. Michael's Hospital, Toronto
  More Information

No publications provided

Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT01616810     History of Changes
Other Study ID Numbers: REB 04-227C
Study First Received: August 26, 2011
Last Updated: June 8, 2012
Health Authority: Canada: Ethics Review Committee

Keywords provided by St. Michael's Hospital, Toronto:
urinary tract

Additional relevant MeSH terms:
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on October 16, 2014